Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment. / Urbak, Lærke; de la Motte, Louise; Rørdam, Peter; Siddiqi, Aamir; Sillesen, Henrik.

In: Annals of Vascular Surgery, Vol. 10, No. 2, 25.06.2017, p. 125-131.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Urbak, L, de la Motte, L, Rørdam, P, Siddiqi, A & Sillesen, H 2017, 'Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment', Annals of Vascular Surgery, vol. 10, no. 2, pp. 125-131. https://doi.org/10.3400/avd.oa.16-00140

APA

Urbak, L., de la Motte, L., Rørdam, P., Siddiqi, A., & Sillesen, H. (2017). Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment. Annals of Vascular Surgery, 10(2), 125-131. https://doi.org/10.3400/avd.oa.16-00140

Vancouver

Urbak L, de la Motte L, Rørdam P, Siddiqi A, Sillesen H. Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment. Annals of Vascular Surgery. 2017 Jun 25;10(2):125-131. https://doi.org/10.3400/avd.oa.16-00140

Author

Urbak, Lærke ; de la Motte, Louise ; Rørdam, Peter ; Siddiqi, Aamir ; Sillesen, Henrik. / Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment. In: Annals of Vascular Surgery. 2017 ; Vol. 10, No. 2. pp. 125-131.

Bibtex

@article{38f91f1fe0dd46a6a1dc11128c1d1370,
title = "Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment",
abstract = "Objective: To evaluate the influence of pre-procedural characteristics on immediate and late results as well as the safety of catheter-directed thrombolysis (CDT) in acute ischemia of the lower extremity. Materials and Methods: A retrospective study comprising 249 patients treated by CDT from January 2006 to December 2012. Outcomes were primary patency, haemorrhagic complications, amputation and mortality. Results: Primary patency for CDT alone was 68%, for CDT plus endovascular treatment 87% and for successful CDT with supplementary surgery 62% giving an overall primary patency of 76%. Two (0.8%) patients suffered from cerebral haemorrhage during CDT. We found a significant correlation between 30 day amputation rate and no visual distal run-off at CDT start (OR 2.31; CI95% 1.09-4.91; p-value=0.02) and onset of symptoms to CDT start of 8-14 days (OR 4.09; CI95% 1.42-11.81; p-value=0.01). Lack of visualized distal run-off was also associated with a significant risk of 30 day mortality (OR 5.84; CI95% 1.26-27.00; p-value=0.02). Conclusion: Our results show that CDT is a feasible and safe treatment option especially when combined with angioplasty +/- stent. However, no distal run-off at primary angiography is associated with higher rates of amputation during follow-up and 30 day mortality.",
author = "L{\ae}rke Urbak and {de la Motte}, Louise and Peter R{\o}rdam and Aamir Siddiqi and Henrik Sillesen",
year = "2017",
month = jun,
day = "25",
doi = "10.3400/avd.oa.16-00140",
language = "English",
volume = "10",
pages = "125--131",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment

AU - Urbak, Lærke

AU - de la Motte, Louise

AU - Rørdam, Peter

AU - Siddiqi, Aamir

AU - Sillesen, Henrik

PY - 2017/6/25

Y1 - 2017/6/25

N2 - Objective: To evaluate the influence of pre-procedural characteristics on immediate and late results as well as the safety of catheter-directed thrombolysis (CDT) in acute ischemia of the lower extremity. Materials and Methods: A retrospective study comprising 249 patients treated by CDT from January 2006 to December 2012. Outcomes were primary patency, haemorrhagic complications, amputation and mortality. Results: Primary patency for CDT alone was 68%, for CDT plus endovascular treatment 87% and for successful CDT with supplementary surgery 62% giving an overall primary patency of 76%. Two (0.8%) patients suffered from cerebral haemorrhage during CDT. We found a significant correlation between 30 day amputation rate and no visual distal run-off at CDT start (OR 2.31; CI95% 1.09-4.91; p-value=0.02) and onset of symptoms to CDT start of 8-14 days (OR 4.09; CI95% 1.42-11.81; p-value=0.01). Lack of visualized distal run-off was also associated with a significant risk of 30 day mortality (OR 5.84; CI95% 1.26-27.00; p-value=0.02). Conclusion: Our results show that CDT is a feasible and safe treatment option especially when combined with angioplasty +/- stent. However, no distal run-off at primary angiography is associated with higher rates of amputation during follow-up and 30 day mortality.

AB - Objective: To evaluate the influence of pre-procedural characteristics on immediate and late results as well as the safety of catheter-directed thrombolysis (CDT) in acute ischemia of the lower extremity. Materials and Methods: A retrospective study comprising 249 patients treated by CDT from January 2006 to December 2012. Outcomes were primary patency, haemorrhagic complications, amputation and mortality. Results: Primary patency for CDT alone was 68%, for CDT plus endovascular treatment 87% and for successful CDT with supplementary surgery 62% giving an overall primary patency of 76%. Two (0.8%) patients suffered from cerebral haemorrhage during CDT. We found a significant correlation between 30 day amputation rate and no visual distal run-off at CDT start (OR 2.31; CI95% 1.09-4.91; p-value=0.02) and onset of symptoms to CDT start of 8-14 days (OR 4.09; CI95% 1.42-11.81; p-value=0.01). Lack of visualized distal run-off was also associated with a significant risk of 30 day mortality (OR 5.84; CI95% 1.26-27.00; p-value=0.02). Conclusion: Our results show that CDT is a feasible and safe treatment option especially when combined with angioplasty +/- stent. However, no distal run-off at primary angiography is associated with higher rates of amputation during follow-up and 30 day mortality.

U2 - 10.3400/avd.oa.16-00140

DO - 10.3400/avd.oa.16-00140

M3 - Journal article

C2 - 29034038

VL - 10

SP - 125

EP - 131

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 2

ER -

ID: 195960436